Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-28 Sale |
2023-08-29 5:04 pm |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $6.2757 | $98,058 | 148,975 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-15 Option Award |
2025-03-18 8:45 pm |
N/A 2035-03-15 |
Structure Therapeutics Inc. | GPCR | Hall Ashley Chief Development Officer |
175,080 | $0 | 242,370 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-20 5:47 pm |
N/A 2034-09-17 |
Structure Therapeutics Inc. | GPCR | Hall Ashley Chief Development Officer |
150,180 | $0 | 150,180 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $1.8 | 148,975 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $0 | 148,975 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:11 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
125,000 | $0 | 160,600 (Direct) |
View |
| 2021-11-12 Option Award |
2021-11-15 7:49 pm |
N/A 2031-11-11 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Hall Ashley Chief Development Officer |
38,000 | $0 | 53,500 (Direct) |
View |